ClinicalTrials.gov
public full text
Public Domain
Drug-Drug Interaction Study: ASP2151 and Montelukast
CYP2C8 is involved in the metabolism of many drugs. So, it is important to assess in vivo the inhibitory effect of ASP2151 on that enzyme to determine any possible drug interactions. The aim of this trial is to investigate the potential for interaction of ASP2151 with the CYP2C8 probe substrate montelukast.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler#842346
- Montelukast in Modulating Exacerbations of Asthma in Children#1102540
- A Study of RO4995819 to Assess Bioavailability and Safety in Healthy Volunteers#863428
- RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease#1073608
- Impact of the butylparaben on the glutathione-dependent enzyme metabolism#955735
Record · ID 1100974
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive